Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells

por Absil, L., Journé, F., Larsimont, D., Body, J. J., Tafforeau, L., Nonclercq, D.
Publicado 2020

Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer

por Tarabichi, M, Saiselet, M, Trésallet, C, Hoang, C, Larsimont, D, Andry, G, Maenhaut, C, Detours, V
Publicado 2015

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

por de Azambuja, E, Cardoso, F, de Castro, G, Colozza, M, Mano, M S, Durbecq, V, Sotiriou, C, Larsimont, D, Piccart-Gebhart, M J, Paesmans, M
Publicado 2007

Early Invasive Cancer and Partial Intraoperative Electron Radiation Therapy of the Breast: Experience of the Jules Bordet Institute

por Philippson, C., Simon, S., Vandekerkhove, C., Hertens, D., Veys, I., Noterman, D., De Neubourg, F., Larsimont, D., Bourgeois, P., Van Houtte, P., Nogaret, J. M.
Publicado 2014

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients

por El Hajj, P, Journe, F, Wiedig, M, Laios, I, Salès, F, Galibert, M-D, Van Kempen, L C, Spatz, A, Badran, B, Larsimont, D, Awada, A, Ghanem, G
Publicado 2013

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

por El Hajj, P, Gilot, D, Migault, M, Theunis, A, van Kempen, L C, Salés, F, Fayyad-Kazan, H, Badran, B, Larsimont, D, Awada, A, Bachelot, L, Galibert, M-D, Ghanem, G, Journe, F
Publicado 2015

Identification of molecular apocrine breast tumours by microarray analysis

por Farmer, P, Bonnefoi, H, Becette, V, Tubiana-Hulin, M, Fumoleau, P, Larsimont, D, MacGrogan, G, Bergh, J, Cameron, D, Goldstein, D, Duss, S, Nicoulaz, A-L, Fiche, M, Brisken, C, Delorenzi, M, Iggo, R
Publicado 2005

Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

por Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J.P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J.M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., Sotiriou, C.
Publicado 2013